Seer Inc. Cl A (SEER): Price and Financial Metrics

Seer Inc. Cl A (SEER): $8.85

0.87 (+10.90%)

POWR Rating

Component Grades













Add SEER to Watchlist
Sign Up

Industry: Biotech



in industry


  • SEER scores best on the Growth dimension, with a Growth rank ahead of 33.65% of US stocks.
  • SEER's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • SEER ranks lowest in Sentiment; there it ranks in the 5th percentile.

SEER Stock Summary

  • SEER's went public 1.32 years ago, making it older than merely 1.72% of listed US stocks we're tracking.
  • SEER's price/sales ratio is 141.63; that's higher than the P/S ratio of 98.13% of US stocks.
  • As for revenue growth, note that SEER's revenue has grown 908.69% over the past 12 months; that beats the revenue growth of 98.89% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Seer Inc are DCTH, QNST, AFRM, LASR, and OKTA.
  • Visit SEER's SEC page to see the company's official filings. To visit the company's web site, go to

SEER Valuation Summary

  • SEER's price/sales ratio is 3745.4; this is 32899.12% higher than that of the median Healthcare stock.
  • Over the past 39 weeks, SEER's price/sales ratio has gone down 24696.8.
  • SEER's price/sales ratio has moved down 24696.8 over the prior 39 weeks.

Below are key valuation metrics over time for SEER.

Stock Date P/S P/B P/E EV/EBIT
SEER 2021-08-31 3745.4 4.7 -75.0 -63.6
SEER 2021-08-30 3586.1 4.5 -71.8 -60.5
SEER 2021-08-27 3468.0 4.3 -69.4 -58.1
SEER 2021-08-26 3447.4 4.3 -69.0 -57.7
SEER 2021-08-25 3398.8 4.2 -68.0 -56.7
SEER 2021-08-24 3315.4 4.1 -66.4 -55.0

SEER Price Target

For more insight on analysts targets of SEER, see our SEER price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.00 Average Broker Recommendation 1.75 (Moderate Buy)

SEER Stock Price Chart Interactive Chart >

Price chart for SEER

SEER Price/Volume Stats

Current price $8.85 52-week high $45.85
Prev. close $7.98 52-week low $6.80
Day low $8.06 Volume 294,300
Day high $8.85 Avg. volume 405,663
50-day MA $10.65 Dividend yield N/A
200-day MA $22.24 Market Cap 552.61M

Seer Inc. Cl A (SEER) Company Bio

Seer, Inc., a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. The company develops Proteograph, an integrated solution comprising consumables, automation instrumentation, and proprietary software that performs proteomics analysis. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

SEER Latest News Stream

Event/Time News Detail
Loading, please wait...

SEER Latest Social Stream

Loading social stream, please wait...

View Full SEER Social Stream

Latest SEER News From Around the Web

Below are the latest news stories about Seer Inc that investors may wish to consider to help them evaluate SEER as an investment opportunity.

Seer to Present at the Cowen 42nd Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating virtually in the upcoming Cowen 42nd Annual Health Care Conference. Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 8 at 11:50 a.m. Pacific Time / 2:50 p.m. Eastern Time. A live webcast of the virtual session will be available on the Investor se

Yahoo | February 22, 2022

Seer, Inc. (SEER) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Seer, Inc. (SEER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

AAP’s education model in Delhi inspired by Guru Ravidas, Ambedkar: Sanjay Singh

Varanasi, Feb 16 (PTI) The education model presented by the Aam Aadmi Party (AAP) in Delhi is derived from the thoughts of Guru Ravidas and B R Ambedkar, party leader Sanjay Singh said here on Wednesday. Singh, the AAP’s in-charge for Uttar Pradesh, said this after paying obeisance at the Guru Ravidas temple at Seer […]

The Print India | February 16, 2022

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

GlobeNewswire | February 1, 2022

SEER''s MV Technologies receives $1.75 in biogas system contracts

As part of a growing number of renewable natural gas projects in the U.S., Strategic Environmental & Energy Resources or SEER (SENR) recently received multiple purchase orders…

Seeking Alpha | January 25, 2022

Read More 'SEER' Stories Here

SEER Price Returns

1-mo 13.83%
3-mo -40.04%
6-mo -58.88%
1-year -70.08%
3-year N/A
5-year N/A
YTD -61.20%
2021 -59.37%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7026 seconds.